Bacterial AT-rich DNA minor groove

The AT-rich minor groove of bacterial double-stranded DNA is a specialized structural region of the genome characterized by a narrow, deep architecture and a high negative electrostatic potential (PubMed: 15575717). These regions are frequently located within essential regulatory elements, such as promoters and origins of replication, where they facilitate the binding of various proteins required for cellular function (PubMed: 11753217). Therapeutic agents known as minor groove binders (MGBs) target these sequences by fitting into the groove through a combination of hydrogen bonding and van der Waals interactions, often displacing the spine of hydration (PubChem: CID 6322). This binding event sterically inhibits the association of vital enzymes, including RNA polymerase and topoisomerases, which effectively halts DNA replication and transcription (PubMed: 25614304). A prominent example of a drug in this class is MGB-BP3, which has shown potent activity against Gram-positive pathogens like Clostridioides difficile by selectively interfering with bacterial gene expression (MGB Biopharma; PubMed: 26923390). Despite their efficacy, a primary challenge in developing these compounds is ensuring sufficient selectivity for bacterial DNA over human nuclear or mitochondrial DNA to avoid off-target toxicity (PubMed: 12633515).

Other names

AT-rich minor groove sequencesBacterial DNA minor grooveMinor groove of bacterial dsDNAAT-rich DNA sequences

Minor groove binders (MGBs) non-covalently bind to the narrow minor groove of AT-rich DNA sequences, displacing water molecules and DNA-binding proteins. This binding stabilizes the DNA duplex and sterically hinders the access of enzymes such as RNA polymerase, DNA polymerase, and topoisomerases, thereby inhibiting essential processes like transcription and replication (PubMed: 25614304).